<DOC>
	<DOCNO>NCT01319695</DOCNO>
	<brief_summary>The use corifollitropin alfa superior term pregnancy outcome parameter compare recombinant follicle stimulate hormone ( FSH ) ovarian stimulation protocol woman undergo vitro fertilisation .</brief_summary>
	<brief_title>Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone ( FSH ) Ovarian Stimulation Women Undergoing Vitro Fertilisation</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Women age 1836 year old body weight 60 kg 90 kg BMI 1832 kg/m2 Menstrual cycle length 2335 day An indication control ovarian stimulation IVF ICSI history endocrine abnormality abnormal outcome blood biochemistry hematology abnormal cervical smear chronic disease uterine pathology interfere COS treatment ( e.g . fibroid â‰¥ 5 cm )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>corifollitropin alfa</keyword>
	<keyword>FSH ovarian stimulation</keyword>
	<keyword>IVF</keyword>
</DOC>